Overexpression of DNAJC6, as shown with increased promoter methylation in cancer subjects, was observed to enhance cell proliferation and invasion suggesting DNAJC6 hypermethylation may be assayed as a putative biomarker for poor outcome in HCC [99]. The gene discussed is DNAJC6; the disease is cancer.